AAPL 192.14 -3.2 (-1.64%)MSFT 117.58 -2.46 (-2.05%)FB 164.73 -1.32 (-0.79%)ZNGA 5.3 -0.13 (-2.31%)NVDA 177.26 -6.63 (-3.61%)WBA 62.56 -1.01 (-1.59%)GOOG 1205.94 -25.16 (-2.04%)PIH 5.45 -0.16 (-2.85%)
AAPL 192.14 -3.2 (-1.64%)MSFT 117.58 -2.46 (-2.05%)FB 164.73 -1.32 (-0.79%)ZNGA 5.3 -0.13 (-2.31%)NVDA 177.26 -6.63 (-3.61%)WBA 62.56 -1.01 (-1.59%)GOOG 1205.94 -25.16 (-2.04%)PIH 5.45 -0.16 (-2.85%)

Financial Statements DOVA Quote Dova Pharma

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Income Statement
Year 201420152016
Revenue 0 0 10
COGS 0 0 1
GrossProfit 0 0 9
Depreciation (included in COGS) 0 0 0
StockBasedCompe (included in COGS) 0 6 12
ResearchAndDeve 0 16 18
SalesGeneralAnd 0 13 62
OperatingIncome 0 -29 -71
InterestExpense 0 1 2
OtherIncome 0 0 1
IncomeBeforeTax 0 -30 -72
ProvisionForInc 0 0 0
NetIncome 0 -30 -72
Balance Sheet
Year 201420152016
CashAndCashEqui 29 95 105
ShortTermInvest 0 0 0
Cash 29 95 105
AccountReceivab 0 0 1
Inventories 0 0 4
DeferredIncomeT 0 0 0
OtherCurrentAss 0 0 0
TotalCurrentAss 29 96 112
PPE 0 0 0
AccumulatedDepr 0 0 0
NetPPE 0 0 0
EquityAndOtherI 0 0 0
Goodwill 0 0 0
IntangibleAsset 0 0 0
OtherLTAssets 0 0 0
TotalNonCurrent 0 0 0
TotalAssets 29 96 112
ShortTermDebt 0 30 7
AccountsPayable 0 1 1
TaxesPayable 0 0 0
AccruedLiabilit 8 4 10
DeferredRevenue 0 0 2
OtherCurrentLia 0 0 2
TotalCurrentLia 8 35 19
Debt 14 0 14
DeferredTaxesLi 0 0 0
DeferredRevenue 0 0 0
OtherLTLiabilit 0 0 0
TotalNonCurrent 14 0 16
TotalLiabilitie 22 35 36
CommonStock 0 0 0
AdditionalPaidI 34 118 206
RetainedEarning -27 -57 -129
AccumulatedOthe 0 0 0
TotalStockholde 7 61 76
TotalLiabilitie 29 96 112
Cash Flow Statement
Year 201420152016
NetIncome 0 -30 -72
Depreciation 0 0 0
DeferredIncomeT 0 0 0
StockBasedCompe 0 6 12
AccountsReceiva 0 0 -1
InventoryCS 0 0 -4
AccountsPayable 0 1 0
OtherWorkingCap 0 -1 3
OtherNonCashIte 0 11 1
NetCashProvided 0 -11 -54
InvestmentsInPP 0 0 0
AcquisitionsNet 0 0 0
PurchasesOfInve 0 0 0
SalesMaturities 0 0 0
PurchasesOfInta 0 -1 0
OtherInvestingA 0 0 0
NetCashUsedForI 0 -1 0
DebtIssued 0 0 20
DebtRepayment 0 0 -31
CommonStockIssu 0 86 80
CommonStockRepu 0 0 0
DividendPaid 0 0 0
OtherFinancingA 0 -8 -5
NetCashProvided 0 78 64
NetChangeInCash 0 66 10
CashAtBeginning 0 29 95
CashAtEndOfPeri 0 95 105
Retained Earnings
Year 201420152016
RetainedEarning ---
NetIncome ---
StockDividend --27
DividendPaid ---
RetainedEarning ---27
Property Plant and Equipment Schedule
Year 201420152016
NetPPE ---
DeprAnnual 0--
CapitalExpendit 000
NetPPE ---
Intangible and Goodwill Schedule
Year 201420152016
intAndGW 0--
Amortization 0--
NewPurchases 0--
intAndGW ---
Dova Pharmaceuticals Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Dova Pharmaceuticals Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.